Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://zoewetx258564.imblogs.net/88599131/trelaglutide-exploring-a-new-therapy-for-chronic-diseases